Fortis Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $931K | Buy |
5,015
+619
| +14% | +$115K | 0.14% | 78 |
|
|
2025
Q1 | $921K | Sell |
4,396
-813
| -16% | -$170K | 0.18% | 70 |
|
|
2024
Q4 | $926K | Sell |
5,209
-697
| -12% | -$124K | 0.17% | 75 |
|
|
2024
Q3 | $1.17M | Buy |
5,906
+26
| +0.4% | +$5.13K | 0.23% | 68 |
|
|
2024
Q2 | $1.01M | Sell |
5,880
-4,358
| -43% | -$748K | 0.22% | 71 |
|
|
2024
Q1 | $1.86M | Buy |
10,238
+237
| +2% | +$43.2K | 0.49% | 44 |
|
|
2023
Q4 | $1.55M | Buy |
10,001
+1,688
| +20% | +$262K | 0.4% | 61 |
|
|
2023
Q3 | $1.24M | Buy |
8,313
+803
| +11% | +$120K | 0.39% | 58 |
|
|
2023
Q2 | $1.01M | Sell |
7,510
-122
| -2% | -$16.4K | 0.36% | 51 |
|
|
2023
Q1 | $1.22M | Buy |
7,632
+453
| +6% | +$72.2K | 0.49% | 33 |
|
|
2022
Q4 | $1.16M | Sell |
7,179
-102
| -1% | -$16.5K | 0.86% | 24 |
|
|
2022
Q3 | $977K | Buy |
7,281
+45
| +0.6% | +$6.04K | 0.83% | 32 |
|
|
2022
Q2 | $1.11M | Sell |
7,236
-514
| -7% | -$78.7K | 1.09% | 23 |
|
|
2022
Q1 | $1.26M | Buy |
7,750
+408
| +6% | +$66.1K | 0.64% | 38 |
|
|
2021
Q4 | $994K | Sell |
7,342
-18,015
| -71% | -$2.44M | 0.52% | 45 |
|
|
2021
Q3 | $2.74M | Buy |
25,357
+19,846
| +360% | +$2.14M | 1.46% | 11 |
|
|
2021
Q2 | $621K | Buy |
5,511
+1,948
| +55% | +$220K | 0.32% | 85 |
|
|
2021
Q1 | $386K | Buy |
3,563
+1,157
| +48% | +$125K | 0.22% | 95 |
|
|
2020
Q4 | $258K | Buy |
+2,406
| New | +$258K | 0.2% | 73 |
|